About VAC4EU

Organisational Structure

Management of VAC4EU is ensured by the following bodies: The General Assembly, the Executive Board and the secretary General and Office. VAC4EU may also create advisory committees: Scientific committees (study specific and open community), Financial Audit and Independent Strategic Advisory Boards and Working Groups within the -Objectives- of VAC4EU in various forms. They are established under the authority of the Executive Board.

Organisational Structure overview

Members of the VAC4EU Association General Assembly can be research organisations (governmental and non-governmental or private), public health institutes, and data access providers under the condition of being qualified and able to provide either access to relevant data and/or relevant expertise to the post-marketing monitoring of vaccines (exposure, coverage, risks, benefits). Publicly listed organizations and drug/vaccine manufacturers cannot be an organizational member of VAC4EU. Applications for Membership shall be addressed in writing to VAC4EU Secretary-General. Membership is granted by the General Assembly upon the proposal of the Executive Board.

The VAC4EU Secretariat is responsible for the following activities

  • Administer and promote VAC4EU

  • Support the work and management of the VAC4EU entities

  • Advocate about the importance of transparent and easy to use evidence on vaccine coverage, benefits and risks

  • Identify and characterize data sources

  • Maintain, update and provide access to the VAC4EU website, data sharing platform, tools and templates

  • Research & business development activities

  • Operate as first contact point and matchmaking for study requests

  • Organize meetings

  • Develop and administer training

The VAC4EU study network is responsible for the following activities

  • Maintain a repository of members and capacity

  • Provide information on data sources (meta-data and database characterization)

  • Conduct vaccine coverage, benefit, risk and benefit/risk studies and monitoring according to VAC4EU endorsed best practice and procedures

  • Provide the community with practical methodological questions

  • Propose, evaluate and implement procedures for generating timely and robust evidence on vaccine coverage, benefits and risks

VAC4EU is managed by the Executive Board whose members are individuals of Members and are elected by the General Assembly. On 12 March 2021 and 14 October 2021 during the 2021 General Assembly meetings, the following Executive Board members have been elected and appointed:

Miriam Sturkenboom
President
Sturkenboom@vac4eu.org

Rosa Gini
Vice-President
Gini@vac4eu.org

Patrick Mahy
Financial Officer
Mahy@vac4eu.org

Eva Molero
Administrator
Molero@vac4eu.org

Daniel Weibel
Secretary General
Weibel@vac4eu.org

Scientific and Strategic Advisory boards, Standing Committees and Topic Groups can be established to address specific matters of common interest within the ‘Objectives’ of VAC4EU under the authority of the Executive Board.

More details about specific rights and obligations as well as activities can be found in the Articles of the Association and the VAC4EU Bylaws

Financial organisation

VAC4EU will finance its activities based on membership fees, grants, donations and testamentary provisions and any transfer not prohibited by law. In addition, VAC4EU may charge for VAC4EU services with cost covering fees. VAC4EU may also receive overheads for services to contract studies by the study network